Sign Out
Enantone 3-Month DPS 11.25 mg: In the event of overdose, the patient must be carefully monitored and a symptomatic and support treatment must be established.
Enantone 6-Month DPS 30 mg: To date, no clinical symptoms of toxicity have been reported. In case of overdose, the patients
should be closely monitored and receive symptomatic and supportive treatment.
Even when administered in daily doses of up to 20 mg for a period of two years, like applied in the first clinical studies, no new side effects or side effects different from those observed with a daily dose of 1 mg or with a dose of 30 mg administered every 6 months have been reported.
